Chief Executive Officer of Biomarin Pharmaceutical Inc (NASDAQ:BMRN), Bienaime Jean Jacques, sells 3,000 shares worth $280,253

According to Biomarin Pharmaceutical Inc's most recent Form 4 filing with the SEC dated Mar 14 02:35 PM, company Chief Executive Officer, Bienaime Jean Jacques disclosed selling 3,000 shares at a cost of $93.42. At the time of this transaction (Mar 13), this trade was worth $280,253 in total. As of Mar 13, Bienaime Jean Jacques now owns 328,701 shares in total worth about $31,282,474.17.

For the last few recent trades made by Biomarin Pharmaceutical Inc (NASDAQ:BMRN) Chief Executive Officer, Bienaime Jean Jacques, we have the following information:

  1. SEC Form 4 filing: Mar 11: Sold 5,000 shares at the rate of $88.96 per share. Total worth of this trade was $444,780. Total number of shares owned as of Mar 11 were 328,701
  2. SEC Form 4 filing: Mar 12: Sold 4,000 shares at the rate of $91.44 per share. Total worth of this trade was $365,770. Total number of shares owned as of Mar 12 were 328,701
  3. SEC Form 4 filing: Mar 07: Sold 4,000 shares at the rate of $90.78 per share. Total worth of this trade was $363,120. Total number of shares owned as of Mar 07 were 328,701
Posted by on Thursday March 14 2019, 3:16 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments closed, Trackbacks open. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in